Article
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
3 May 2021
Abstract excerpt
Multi-subunit ATPase-dependent chromatin remodelling complexes SWI/SNF (switch/sucrose non-fermentable) are fundamental epigenetic regulators of gene transcription. Functional genomic studies revealed a remarkable mutation prevalence of SWI/SNF-encoding genes in 20-25% of all human cancers, frequently driving oncogenic programmes. Some SWI/SNF-mutant cancers are hypersensitive to perturbations in other SWI/SNF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
